89bio Inc Stock Short Ratio
| ETNB Stock | USD 8.96 0.20 2.28% |
89bio Inc fundamentals help investors to digest information that contributes to 89bio's financial success or failures. It also enables traders to predict the movement of 89bio Stock. The fundamental analysis module provides a way to measure 89bio's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to 89bio stock.
89bio | Short Ratio |
89bio Inc Company Short Ratio Analysis
89bio's Short Ratio is typically used by traders and speculators to identify trends in current market sentiment for a particular equity instrument. In its simple terms this ratio shows how many days it will take all current short sellers to cover their positions if the price of a stock begins to rise.
Current 89bio Short Ratio | 10.28 X |
Most of 89bio's fundamental indicators, such as Short Ratio, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, 89bio Inc is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
89bio Short Ratio Driver Correlations
Understanding the fundamental principles of building solid financial models for 89bio is extremely important. It helps to project a fair market value of 89bio Stock properly, considering its historical fundamentals such as Short Ratio. Since 89bio's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of 89bio's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of 89bio's interrelated accounts and indicators.
Click cells to compare fundamentals
The higher the Short Ratio, the longer it would take to buy back the borrowed shares. In theory, the more short positions are currently outstanding, the faster it will be to cover shorted positions.
| Competition |
Based on the latest financial disclosure, 89bio Inc has a Short Ratio of 10.28 times. This is 163.59% higher than that of the Biotechnology sector and 38.73% higher than that of the Health Care industry. The short ratio for all United States stocks is 157.0% lower than that of the firm.
89bio Short Ratio Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses 89bio's direct or indirect competition against its Short Ratio to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of 89bio could also be used in its relative valuation, which is a method of valuing 89bio by comparing valuation metrics of similar companies.89bio is currently under evaluation in short ratio category among its peers.
89bio Current Valuation Drivers
We derive many important indicators used in calculating different scores of 89bio from analyzing 89bio's financial statements. These drivers represent accounts that assess 89bio's ability to generate profits relative to its revenue, operating costs, and shareholders' equity. Below are some of 89bio's important valuation drivers and their relationship over time.
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Market Cap | 279.7M | 392.1M | 262.7M | 443.1M | 398.8M | 235.7M | |
| Enterprise Value | 186.3M | 187.4M | 131.3M | 407.9M | 367.1M | 385.4M |
89bio ESG Sustainability
Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary and do not directly affect the long term financial condition, 89bio's sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to 89bio's managers, analysts, and investors.Environmental | Governance | Social |
89bio Institutional Holders
Institutional Holdings refers to the ownership stake in 89bio that is held by large financial organizations, pension funds or endowments. Institutions may purchase large blocks of 89bio's outstanding shares and can exert considerable influence upon its management. Institutional holders may also work to push the share price higher once they own the stock. Extensive social media coverage, TV shows, articles in high-profile magazines, and presentations at investor conferences help move the stock higher, increasing 89bio's value.| Shares | Citadel Advisors Llc | 2024-09-30 | 2.6 M | Geode Capital Management, Llc | 2024-09-30 | 2.1 M | Redmile Group, Llc | 2024-09-30 | 1.6 M | Millennium Management Llc | 2024-06-30 | 1 M | Goldman Sachs Group Inc | 2024-06-30 | 904.8 K | Exoduspoint Capital Management, Lp | 2024-09-30 | 871.4 K | Candriam Luxembourg S.c.a. | 2024-06-30 | 848.1 K | Laurion Capital Management Lp | 2024-09-30 | 810.5 K | Alyeska Investment Group, L.p. | 2024-09-30 | 808.6 K | Ra Capital Management, Llc | 2024-09-30 | 14.2 M | Hhg Plc | 2024-06-30 | 13.3 M |
89bio Fundamentals
| Return On Equity | -0.73 | ||||
| Return On Asset | -0.41 | ||||
| Current Valuation | 643.81 M | ||||
| Shares Outstanding | 117.58 M | ||||
| Shares Owned By Insiders | 0.57 % | ||||
| Shares Owned By Institutions | 93.66 % | ||||
| Number Of Shares Shorted | 5.38 M | ||||
| Price To Earning | (1.04) X | ||||
| Price To Book | 2.72 X | ||||
| EBITDA | (134.46 M) | ||||
| Net Income | (142.19 M) | ||||
| Cash And Equivalents | 193.34 M | ||||
| Cash Per Share | 4.16 X | ||||
| Total Debt | 27.11 M | ||||
| Debt To Equity | 0.13 % | ||||
| Current Ratio | 5.81 X | ||||
| Book Value Per Share | 3.56 X | ||||
| Cash Flow From Operations | (129.19 M) | ||||
| Short Ratio | 10.28 X | ||||
| Earnings Per Share | (2.96) X | ||||
| Price To Earnings To Growth | (0.45) X | ||||
| Target Price | 30.13 | ||||
| Number Of Employees | 70 | ||||
| Beta | 0.98 | ||||
| Market Capitalization | 1.03 B | ||||
| Total Asset | 596.27 M | ||||
| Retained Earnings | (457.43 M) | ||||
| Working Capital | 563.92 M | ||||
| Current Asset | 10.12 M | ||||
| Current Liabilities | 3.89 M | ||||
| Net Asset | 596.27 M |
About 89bio Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze 89bio Inc's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of 89bio using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of 89bio Inc based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether 89bio Inc offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of 89bio's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of 89bio Inc Stock. Outlined below are crucial reports that will aid in making a well-informed decision on 89bio Inc Stock:Check out 89bio Piotroski F Score and 89bio Altman Z Score analysis. You can also try the Cryptocurrency Center module to build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of 89bio. If investors know 89bio will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about 89bio listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (2.96) | Return On Assets (0.41) | Return On Equity (0.73) |
The market value of 89bio Inc is measured differently than its book value, which is the value of 89bio that is recorded on the company's balance sheet. Investors also form their own opinion of 89bio's value that differs from its market value or its book value, called intrinsic value, which is 89bio's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because 89bio's market value can be influenced by many factors that don't directly affect 89bio's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between 89bio's value and its price as these two are different measures arrived at by different means. Investors typically determine if 89bio is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, 89bio's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.